Lisopress

Quick links to important sections

Medically reviewed

Marina Burgos

Last updated on 22/12/2025

This page provides general, reference-level information compiled from official medical sources. It is not a substitute for professional medical advice, diagnosis, or treatment. For decisions about your health, please consult a qualified healthcare professional.

Overview of Lisopress

Lisopress is a brand name for the prescription medicine whose core therapeutic component is the active ingredient Lisinopril, a synthetic substance used primarily to manage cardiovascular conditions. It belongs to the pharmacological group known as Angiotensin-Converting Enzyme (ACE) inhibitors, functioning as a critical antihypertensive agent to support heart health.


Property Description
Active ingredient Lisinopril
Form Immediate-release tablet
Pharmacological class ACE inhibitor
General purpose Reduce high blood pressure
Origin Synthetic compound

What Type of Medicine is Lisopress?

Lisopress is classified as an Angiotensin-Converting Enzyme (ACE) inhibitor, which is a widely recognized class of cardiovascular drugs commonly utilized in clinical practice. This class of medication is essential for lowering blood pressure by promoting the widening of blood vessels. This classification signifies its specific role in modulating the body’s established hormonal system for controlling blood pressure. The product is a single-ingredient product, containing only Lisinopril, which allows for precise control when used as monotherapy or combined separately with other necessary medications.


Composition, Origin, and Form

The medication’s composition is centered on Lisinopril, which is structurally defined as a dipeptide derivative and is entirely a synthetic compound, meaning it is not naturally sourced. Lisopress is supplied as an immediate-release tablet, establishing it as a solid oral dosage form intended for simple oral administration. The pharmaceutical packaging of the Lisopress brand emphasizes patient convenience, differentiating it from generic versions which may vary in tablet size, color, and manufacturer, though the active ingredient remains identical.


General Purpose and Mechanism Principle

The overarching general purpose of Lisopress is to mitigate and control high blood pressure and ease the strain on the heart, a therapeutic goal clinically recognized for reducing the long-term risk associated with cardiovascular disease. This is achieved by the drug’s ability to promote easier blood flow throughout the body. As an ACE inhibitor, its underlying mechanism involves the inhibition of the Angiotensin-Converting Enzyme, a process that reduces the body's ability to produce the potent vasoconstrictor known as Angiotensin II. This action allows blood vessels to relax (vasodilation) and decreases the overall resistance to blood flow, which is the foundational principle for its effectiveness in cardiovascular management.

Regulatory References

  1. U.S. National Library of Medicine
  2. MedlinePlus

What side effects are possible with Lisopress?

Possible Side Effects and Safety Information

This information is based on official government regulatory documents (e.g., FDA, EMA) and summarizes the documented risks and safety profile of Lisopress (lisinopril). This is not an exhaustive list of all side effects.


Serious and Clinically Significant Risks

Angioedema is a serious and potentially life-threatening adverse reaction involving rapid swelling of the face, lips, tongue, and/or throat, which may cause difficulty breathing. This risk is higher in Black patients and those with a prior history of angioedema related to an ACE inhibitor. Fetal Toxicity is a major safety concern; Lisopress is contraindicated during the second and third trimesters of pregnancy due to documented harm and death to the developing fetus. Severe Hypotension (very low blood pressure) can occur, especially following the first dose.

Common Adverse Reactions

The most frequently observed side effects reported in clinical trials, occurring in a significant percentage of patients, include:

  • Dizziness
  • Headache
  • A persistent, dry Cough

Safety Restrictions and Monitoring

Contraindications restrict the use of Lisopress in patients with a history of angioedema, concurrent use with certain drugs like sacubitril/valsartan or aliskiren (in diabetic patients), and known hypersensitivity. Monitoring is required for serious potential effects, including:

  • Renal Function: Regular monitoring of kidney function (creatinine and GFR) is necessary, as the drug can cause or worsen renal impairment.
  • Hyperkalemia: Monitoring of serum potassium is required, as the medicine can lead to elevated potassium levels.

Lisopress is generally not recommended for use in children under 6 years of age or those with severe renal impairment.

Overdose and Emergency Response

Lisopress Overdose and when to seek help

The official regulatory documentation for Lisopress (Lisinopril) identifies the most likely clinical manifestation of overdosage as profound hypotension (low blood pressure), which is an exaggerated extension of its therapeutic effect. Manifestations of severe overdosage may include severe lightheadedness or fainting (syncope). Taking an excessive amount of the medicine requires immediate medical attention.

Overdosage carries the risk of severe, life-threatening outcomes, including acute renal failure and electrolyte imbalances such as hyperkalaemia (high serum potassium). Due to the potential for these complications, emergency services must be contacted immediately if overdosage is suspected or if clinical signs of severe hypotension, such as collapse, are observed.

There is no specific antidote known for Lisinopril. Management is strictly symptomatic and supportive. Regulatory authorities describe the usual treatment for overdosage-induced hypotension as the intravenous infusion of normal saline solution to restore fluid volume and pressure. Furthermore, hemodialysis is documented as a procedure that can effectively remove Lisinopril from the systemic circulation. Continuous hospital monitoring of vital signs, fluid status, and laboratory parameters is necessary following overdosage.

Therapeutic Uses of Lisopress

Main Uses of Lisopress

Lisopress is a medication belonging to the class of ACE (angiotensin-converting enzyme) inhibitors. It is primarily prescribed for the management of cardiovascular conditions and the protection of renal function in certain patient groups.

Hypertension (High Blood Pressure)

The primary use of Lisopress is the treatment of hypertension. It works by relaxing the blood vessels, which allows blood to flow more easily and reduces the workload on the heart. Maintaining blood pressure within a target range is essential for reducing the risk of long-term complications such as stroke and myocardial infarction.

Heart Failure

Lisopress is used as part of a comprehensive management plan for heart failure. In patients whose heart muscle is unable to pump blood effectively, this medication helps improve cardiac output and reduce systemic resistance. Clinical use has shown that it can help manage symptoms, improve quality of life, and reduce the frequency of hospitalizations related to heart failure.

Acute Myocardial Infarction

Following a heart attack (myocardial infarction), Lisopress may be administered to hemodynamically stable patients. The goal of treatment in this context is to prevent the development of heart failure and increase the chances of long-term survival by preventing the remodeling of heart tissue.

Diabetic Nephropathy

In patients with type 2 diabetes and hypertension, Lisopress is utilized to treat kidney disease (nephropathy). It helps slow the progression of renal damage by reducing the pressure within the filtering units of the kidneys and decreasing the amount of protein leaked into the urine.

Benefits of Treatment

  • Cardiovascular Protection: By lowering systemic blood pressure, the medication reduces the strain on the arteries and the heart muscle.
  • Organ Preservation: It provides specific protective effects for the kidneys, particularly in patients with metabolic disorders.
  • Long-term Management: It serves as an effective foundational therapy for chronic conditions that require consistent physiological regulation.

Regulatory References

  1. Lisinopril: MedlinePlus Drug Information

Eligibility and Restrictions for Use

Eligibility Map: Who can and cannot use Lisopress

The official regulatory profile for Lisopress (Lisinopril) establishes specific criteria for patient eligibility, strictly defining groups that are allowed, restricted, or prohibited from using the medicine.


Absolute Contraindications (Prohibited Use)

Lisopress is contraindicated and must not be used by certain populations:

  • Women who are in the second or third trimesters of pregnancy due to risk of fetal injury.
  • Anyone with a history of angioedema related to a previous ACE inhibitor or with hereditary/idiopathic angioedema.
  • Patients with known hypersensitivity to Lisinopril or any other ACE inhibitor.
  • Patients taking a neprilysin inhibitor (e.g., sacubitril/valsartan) or within 36 hours of taking one.

Age and Condition-Based Restrictions

Adults are generally eligible for approved uses, but use is restricted for certain age groups and conditions:

  • Pediatric patients must be 6 years of age or older and are only eligible for the treatment of hypertension, provided they have adequate renal function.
  • Use in children under 6 years is not established or not recommended.
  • Patients with Renal Impairment (CrCl 10 - 30 mL/min) or who are volume-depleted require a reduced initial dose and close medical monitoring.
  • Use during breastfeeding is generally not recommended.

What should I know about interactions with other medicines?

Interactions with other medicines and products

The official interaction profile for Lisopress (Lisinopril) is defined by the regulatory guidance on concurrent administration with specific medicines and substances.


Formal Contraindicated Combinations

Lisinopril is formally contraindicated with several agents and procedures due to the risk of severe adverse outcomes. The use of Aliskiren is prohibited in patients who have diabetes mellitus. Lisinopril must not be initiated within 36 hours of the last dose of a Neprilysin Inhibitor (e.g., Sacubitril) due to the documented risk of angioedema. Use during hemodialysis involving certain high-flux membranes is also prohibited because of the risk of anaphylactoid reactions.


Clinically Significant Interaction Patterns

Co-administration with agents that affect potassium balance, such as potassium-sparing diuretics and potassium supplements, significantly increases the risk of hyperkalemia (high serum potassium levels). Combining Lisinopril with Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) may both reduce the antihypertensive effect and increase the risk of worsening renal function; this risk is particularly noted for the elderly and those with pre-existing renal impairment. Furthermore, Lisinopril causes an officially documented increase in serum lithium concentrations due to reduced clearance of lithium, and the co-administration of mTOR Inhibitors is associated with an increased risk of angioedema. Regulatory documents confirm that the absorption of Lisinopril is not influenced by food.

Mechanism of Action

Lisopress is a competitive inhibitor targeting the Angiotensin-Converting Enzyme (ACE), a peptidyl dipeptidase. This enzyme is present on the luminal surface of endothelial cells, particularly in the pulmonary, renal, and systemic vasculature.

Lisopress binding prevents ACE from catalyzing the conversion of Angiotensin I to the biologically active Angiotensin II within the Renin-Angiotensin-Aldosterone System (RAAS). The resulting decrease in circulating and tissue Angiotensin II levels leads to reduced stimulation of the Angiotensin II type 1 ( AT1) receptors on vascular smooth muscle cells and the adrenal cortex. Intracellularly, this diminishes the AT1-mediated signaling cascade, which typically promotes vasoconstriction and aldosterone release.

Downstream, the suppression of Angiotensin II activity leads to arterial vasodilation and a reduction in aldosterone secretion from the adrenal glands. This reduced aldosterone level decreases sodium and water reabsorption and increases potassium excretion in the renal collecting ducts. Furthermore, ACE is identical to kininase II, the enzyme that degrades bradykinin, a potent vasodilator peptide. Inhibition of ACE may lead to an accumulation of bradykinin, contributing an additional vasodilatory effect. The net system-level physiological consequence is a decrease in total peripheral vascular resistance and modulation of fluid volume homeostasis.

Dosage and Administration Information

Lisopress is administered orally and is primarily supplied as an immediate-release tablet. The standard administration pattern is a once daily (qDay) regimen, which should be taken at approximately the same time each day to maintain a consistent level in the body. The medicine can be taken with or without food, as its absorption is not influenced by the presence of a meal.

Official Dosing and Regimen Structure

Usage involves initiating therapy with a low, condition-specific starting dose, followed by a period of titration, or gradual adjustment, to reach the usual maintenance dose. The dose must be adjusted according to the patient's response and tolerance, typically over intervals of two to four weeks, depending on the condition being addressed.

Indication Initial Dose (Adults) Usual Maintenance Range (Adults)
Hypertension (Monotherapy) 10 mg once daily 20 mg to 40 mg once daily
Heart Failure 2.5 mg to 5 mg once daily Up to 40 mg once daily

Population-Specific Use and Adjustments

Dose modification is required for certain patient groups. For adults with renal impairment (creatinine clearance le 30 mL/min), the initial dose is generally halved from the usual starting amount. For pediatric patients aged 6 years and older, a weight-based starting dose of 0.07 mg/kg (up to 5 mg total) once daily is specified. When a dose is missed, the standard practice is to take it as soon as possible, but if it is nearly time for the next scheduled dose, the missed dose should be skipped.

Recent Clinical Evidence

Research Evidence / Overview of Studies for Lisopress

This section summarizes the published clinical research involving Lisopress (Lisinopril). This information is descriptive of the studies themselves and does not offer clinical advice, dosing instructions, or personal recommendations.


Evidence for Use in Chronic High Blood Pressure (Hypertension)

Research exploring Lisopress for conditions characterized by high blood pressure has involved large Randomized Controlled Trials (RCTs) and systematic reviews that compared the medication against both placebo and other types of blood pressure treatments. These studies was evaluated in populations of adult patients with varying degrees of hypertension, and also included pediatric patients aged 6 and older.

The key research examined outcomes related to physiological strain, specifically measuring changes in systolic and diastolic blood pressure. Over the long term, studies also monitored the frequency of major cardiovascular events, such as stroke and myocardial infarction. Findings from large comparative trials suggest that Lisopress was studied for effects on measured blood pressure, and data show patterns related to cardiovascular event incidence that described patterns observed in the studies.


Evidence for Use in Chronic Heart Failure and Post-Heart Attack Care

Research has explored Lisopress in patients with conditions involving functional limitations of the heart, specifically those with chronic heart failure (reduced ejection fraction) and those who have recently experienced an acute heart attack.

For Chronic Heart Failure, large, long-term RCTs, such as the ATLAS trial, was observed in populations with reduced heart function. These studies monitored outcomes reflecting daily functioning by tracking rates of hospitalization and all-cause mortality over median follow-up durations of several years. Findings indicate patterns where higher doses was observed in some studies to have different frequencies of death or hospitalization when compared to lower doses, although differences in mortality alone were not always clearly established across all studies.

For Post-Heart Attack Care, studies focused on initiating therapy within 24 hours of the event in hemodynamically stable patients. The research examined outcomes related to systemic or functional imbalance, such as all-cause mortality and measures of severe left ventricular dysfunction (a type of heart damage), typically over a short-term period of 6 weeks. Data show patterns related to the monitored incidence of these critical outcomes, and research suggests a pattern that may continue in the longer term.

Key Studies & References

  1. Lisinopril: MedlinePlus Drug Information

Frequently Asked Questions (FAQ)

Common questions about Lisopress (FAQ)


Q: How quickly does Lisopress start working?

According to official product information, the blood pressure lowering effect begins around one hour after taking a dose, with the maximum reduction of blood pressure typically observed around six hours. However, achieving the best long-term control of blood pressure may require the medication to be taken consistently for two to four weeks.


Q: How long do the effects of Lisopress last after I take it?

Studies and official information indicate that the blood pressure-lowering effects of the medicine are generally maintained for at least 24 hours after taking a single daily dose. This duration is consistent with the medication's official once-daily administration pattern.


Q: Does Lisopress affect kidney function?

Yes, regulatory documents state that Lisopress can potentially worsen or cause renal impairment (kidney damage) and may increase creatinine levels, which is a measure of kidney function. For this reason, official guidelines state that periodic monitoring of kidney function is generally necessary during therapy.


Q: Can Lisopress affect my sleep?

Official adverse reaction reports list side effects related to sleep, although they are generally uncommon. These include reports of insomnia (difficulty sleeping) and somnolence (drowsiness).


Q: Is it common to feel dizzy after starting Lisopress?

Dizziness is a very common side effect reported in clinical trials, especially when starting therapy. The official product label cautions that patients should be aware of lightheadedness, particularly when changing posture (such as standing up quickly).


Q: Is Lisopress a diuretic (water pill)?

Lisopress (Lisinopril) is classified as an Angiotensin-Converting Enzyme (ACE) inhibitor, not a diuretic. However, its method of action does lead to a decrease in the reabsorption of sodium and water in the kidneys, which can have a diuretic-like effect.


Q: Can I take vitamins or supplements while using Lisopress?

Official regulatory information specifically states that salt substitutes containing potassium should be avoided unless otherwise instructed, due to the drug’s potential to increase potassium levels. Additional potassium from supplements could contribute to high potassium levels (Hyperkalemia).


Q: Does Lisopress cause changes in blood sugar levels?

Official reports note that Lisinopril has been associated with causing hypoglycemia (low blood sugar) in patients who have diabetes, particularly when they are also taking insulin or other antidiabetic medicines.


Q: Are there warnings about Lisopress and driving or operating machinery?

Official product information advises that because the medicine can cause dizziness or fainting, patients should be aware of how they react to the drug before performing tasks that require concentration, such as driving or operating hazardous machinery.


Q: What should I tell a new doctor about my Lisopress use?

Official patient information indicates that a physician should be informed about Lisopress use, as well as any lightheadedness, fainting spells, or signs of infection (like a sore throat or fever). It is also important to mention if potassium-containing salt substitutes are used.


Q: Is it possible to develop a tolerance to Lisopress?

Clinical studies summarized in regulatory documents indicate that the beneficial effects of Lisinopril in lowering blood pressure are maintained during long-term therapy, suggesting that no loss of effect is expected.


Q: Does Lisopress cause any gastrointestinal issues like nausea?

Official adverse reaction documents list nausea as a common side effect reported in clinical trials. Other related gastrointestinal issues that have been reported include vomiting and diarrhea.


Q: How is Lisopress removed from the body?

Lisopress is primarily removed from the body by the kidneys. The medicine is excreted unchanged entirely in the urine, meaning the body does not metabolize or break it down before removal. It can also be removed from the bloodstream by hemodialysis.


Q: Can Lisopress cause problems with electrolytes?

Official warnings indicate that Lisopress can increase the risk of Hyperkalemia, which is a high level of potassium in the blood. For this reason, official safety information states that the regular monitoring of serum potassium levels is required.


Q: What is the expected long-term duration of Lisopress use?

Lisinopril is indicated for the chronic management of long-term conditions like heart failure and high blood pressure. Clinical research documents show that its effects are maintained during long-term therapy, with studies tracking patient outcomes over periods of several years.


Q: Why do some people experience a cough with Lisopress?

The persistent, dry cough associated with Lisopress is thought to be caused by the drug’s action as an ACE inhibitor. By blocking the ACE enzyme, a substance called bradykinin can accumulate in the airways, which is believed to stimulate the nerves that cause the coughing sensation.


Q: Are there reported interactions between Lisopress and alcohol?

Official drug interaction summaries suggest that alcohol (ethanol) may have an additive effect on lowering blood pressure when combined with Lisinopril. This combination could increase the risk of symptoms such as headache, lightheadedness, and dizziness.


Q: What are the signs that Lisopress is causing a serious problem?

Regulatory documents list Angioedema (swelling of the face, lips, tongue, or throat that can make breathing difficult) as a potentially severe adverse reaction. Other serious risks include symptoms of severe hypotension, such as fainting or acute confusion.


Q: Can I stop taking Lisopress once my condition improves?

Lisopress is used to control conditions like high blood pressure and heart failure, as these conditions are not typically cured by this medication. The medicine is designed for ongoing daily administration to manage chronic conditions and help maintain therapeutic goals.


Q: Does Lisopress help with anxiety?

The medicine is not indicated for treating anxiety, as its primary purpose is the management of cardiovascular conditions. Official regulatory documents list anxiety as an uncommon adverse reaction.


Q: What if Lisopress doesn't seem to be working for me?

The dosage of Lisopress may be gradually adjusted over several weeks to find the optimal effect, a process known as titration. Therapeutic evaluation may also involve checking for other factors, such as underlying medical conditions or potential drug interactions that could affect its action.

How should Lisopress be stored and disposed of?

How to Store and Dispose of Lisopress?

Lisinopril tablets (Lisopress) must be stored and handled according to specific regulatory requirements to maintain product stability and ensure safety.

Storage Requirements

Condition Regulatory Requirement
Temperature Store at Controlled Room Temperature (20°C to 25°C / 68°F to 77°F).
Protection Keep in a tightly closed container to protect the tablets from moisture.
Child Safety Must be stored out of the sight and reach of children.

Disposal Instructions

Expired or unused tablets should not be flushed down the toilet. The preferred method for disposal is using an authorized drug take-back program. If a program is unavailable, follow the precautionary household trash procedure by mixing the tablets with an unappealing substance like dirt or cat litter and sealing the mixture before placing it in the trash.

Attention! Always consult to a doctor or pharmacist before using pills or medicines.

Available in countries:

Equivalent of Lisopress found in:

A-Z Index: